With reviews of Apple's new small tablet - the iPad Mini 3 - revealing that the device its essentially the same as its predecessor, the iPad Mini 2, it is being speculated that Apple may discontinue its small tablet lineup; and the iPad Mini 3 could possibly be the last 7.9-inch iPad Mini tablet.
The introduction of iPad Mini 3 - along with new iPad Air 2 - by Apple in October reportedly left the Internet stunned because of the level of sameness between the new iPad Mini and the existing model.
Technically, the new iPad Mini 3 was quite identical to the iPad Mini 2, except for the addition of Touch ID and a new color option --- gold.
However, with the retail cost of the new iPad Mini 3 being $110 more than that of iPad Mini 2, Apple has boldly defended the asking price of the new small tablet with the declaration that the introduction of Touch ID on the new device is more than enough to justify its higher price-tag than its predecessor.
Meanwhile, with the latest iPhone 6 Plus phablet featuring an impressive 5.5-inch screen display, it is being rumored that Apple will probably drop the iPad Mini tablet lineup; especially since the iPhone 6 Plus successors will probably be equipped with even bigger screens.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).